Disease/Infection News

RSS

Study: One half of hospitalized COVID-19 patients experience persistent symptoms after one year

Most symptoms of COVID-19 in hospitalized patients are resolved within 12 months, however, around one half still experience at least one persistent symptom, a study of 1,276 patients from Wuhan, China, published in The Lancet, has found.

27 Aug 2021

Study examines safety of COVID-19 vaccine in a nationwide mass-vaccination setting

The Clalit Research Institute, in collaboration with researchers from Harvard University, analyzed one of the world's largest integrated health record databases to examine the safety of the Pfizer/BioNTech BNT162B2 vaccine against COVID-19.

27 Aug 2021

Post-traumatic stress symptoms in COVID-19 survivors linked with changes to the brain's connectivity

COVID-19 survivors report significantly higher symptoms of post-traumatic stress, and these symptoms are associated with changes to the brain's connectivity, according to a study coauthored by Vince Calhoun, Distinguished Professor of Psychology at Georgia State University and director of the Center for Translational Research in Neuroimaging and Data Science (TReNDS).

27 Aug 2021

COVID-19 vaccine potency has diminished in recent months, but still helps in saving lives

COVID-19 vaccines remain effective, but their potency has diminished in recent months, according to a nationwide study at eight sites, including Salt Lake City, Utah.

27 Aug 2021

SUSU scientists conduct CFD study to monitor the spread of respiratory viruses in enclosed areas

Scientists from the South Ural State University have conducted a CFD Study for monitoring the spread of respiratory viruses in closed spaces.

27 Aug 2021

Certain high priority groups more likely to stop taking HIV prevention treatment, study finds

A large, detailed look at patients taking HIV-prevention drug therapy finds strong adherence soon after patients get the prescription, but less consistent use thereafter, particularly among groups considered high priority for receiving the medication.

27 Aug 2021

Study: 31% of Americans had been infected with SARS-CoV-2 by the end of 2020

A new study published in the journal Nature estimates that 103 million Americans, or 31 percent of the U.S. population, had been infected with SARS-CoV-2 by the end of 2020.

27 Aug 2021

Pediatric cancer patients fare worse with COVID-19 than children without cancer

Research from a large international effort shows that 20% of children with cancer who are infected with SARS-CoV-2 develop severe infections.

27 Aug 2021

COVID-19 pandemic illuminates the importance of airborne transmission of respiratory viruses

SARS-CoV-2, the virus behind today's global coronavirus pandemic, spreads primarily by inhalation of virus-laden aerosols at both short and long ranges -;and a comprehensive new assessment of respiratory viruses finds that many others probably do as well.

27 Aug 2021

Improved understanding of aerosol transmission could help control airborne respiratory viruses

The COVID-19 pandemic has revealed critical knowledge gaps and assumptions concerning how respiratory viruses spread between hosts.

27 Aug 2021

New blood test could save thousands of lives by predicting sepsis before symptoms appear

Clinicians at Portsmouth's Queen Alexandra Hospital are leading medical trials of a blood test that could help to save thousands of UK lives a year by predicting sepsis days before patients show any symptoms.

26 Aug 2021

Preliminary study suggests nitric oxide may be a potential treatment for COVID-19 respiratory failure

New research led by Devang K. Sanghavi of the Mayo Clinic in Florida, USA, suggests pre-intubation use of nitric oxide for patients with COVID-19–related hypoxemic respiratory may help reduce patients' mortality. Their findings show that inhaling nitric oxide in this patient population could reduce the need for future intubation and other invasive mechanical ventilation.

26 Aug 2021

German study shows high protection from COVID-19 in over 80s with Pfizer vaccine

A new observational study in Germany, recently published on the medRxiv* preprint server, found the Comirnaty vaccine to be 68.3% effective against COVID-19 for people over 80. In those fully immunized, the vaccine was found to be 73.2% effective in preventing hospitalization and 80.1% effective against death.

26 Aug 2021

Oral mucosa identified as potential target for SARS-CoV-2 infection

A recent study suggested that ACE2 receptors are expressed in oral tissues, making the oral cavity an important potential entry point of SARS-CoV-2.

26 Aug 2021

Aging reduces the risk of developing genetically related diseases

Unexpected findings provide insights into how aging and genetically determined diseases are associated.

26 Aug 2021

Migraines may hold the key to new treatment for diabetes

The mechanistic association between migraines and type 2 diabetes reveals a new approach to treat diabetes.

26 Aug 2021

Potential variant of interest in South Africa assigned to the PANGO lineage C.1.2

Continual genomic surveillance of the SARS-CoV-2 strains in South Africa has revealed an increase in the number of sequences belonging to C.1 lineage during the third wave (May 2021) of SARS-CoV-2 infections. This observation was unexpected because C.1 was last reported in January 2021.

26 Aug 2021

The influence of COVID-19 on platelet activation and aggregation

In a paper recently uploaded to the bioRxiv* preprint server, humanized ACE2 mice are infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and platelets are subsequently isolated from the blood for quantitative proteomic analysis.

26 Aug 2021

Scientists assess SARS-CoV-2 mutants in ferret hosts

In a paper recently uploaded to the preprint server bioRxiv* by the cause of SARS-CoV-2 mutations observed in mink and ferrets is investigated, and the danger posed by such mutations to humans assessed.

26 Aug 2021

Large UK study examines impact of Delta variant on viral burden and vaccine effectiveness

Now, a new study published on the medRxiv* preprint server focused on determining the effectiveness of the BNT162b2, ChAdOx1, and mRNA-1273 vaccines by conducting SARS-CoV-2 PCR-positive tests.

26 Aug 2021

Disease/Infection News

Study: One half of hospitalized COVID-19 patients experience persistent symptoms after one year

Study examines safety of COVID-19 vaccine in a nationwide mass-vaccination setting

Post-traumatic stress symptoms in COVID-19 survivors linked with changes to the brain's connectivity

COVID-19 vaccine potency has diminished in recent months, but still helps in saving lives

SUSU scientists conduct CFD study to monitor the spread of respiratory viruses in enclosed areas

Certain high priority groups more likely to stop taking HIV prevention treatment, study finds

Study: 31% of Americans had been infected with SARS-CoV-2 by the end of 2020

Pediatric cancer patients fare worse with COVID-19 than children without cancer

COVID-19 pandemic illuminates the importance of airborne transmission of respiratory viruses

Improved understanding of aerosol transmission could help control airborne respiratory viruses

New blood test could save thousands of lives by predicting sepsis before symptoms appear

Preliminary study suggests nitric oxide may be a potential treatment for COVID-19 respiratory failure

German study shows high protection from COVID-19 in over 80s with Pfizer vaccine

Oral mucosa identified as potential target for SARS-CoV-2 infection

Aging reduces the risk of developing genetically related diseases

Migraines may hold the key to new treatment for diabetes

Potential variant of interest in South Africa assigned to the PANGO lineage C.1.2

The influence of COVID-19 on platelet activation and aggregation

Scientists assess SARS-CoV-2 mutants in ferret hosts

Large UK study examines impact of Delta variant on viral burden and vaccine effectiveness

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News